Found: 56
Select item for more details and to access through your institution.
Four-Year Visual Outcomes After Intravitreous Aflibercept for Vision-Threatening Complications of Diabetic Retinopathy—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 20, p. 1796, doi. 10.1001/jama.2023.6715
- By:
- Publication type:
- Article
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 5, p. 376, doi. 10.1001/jama.2022.25029
- By:
- Publication type:
- Article
Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.
- Published in:
- JAMA Ophthalmology, 2023, v. 141, n. 3, p. 268, doi. 10.1001/jamaophthalmol.2022.6142
- By:
- Publication type:
- Article
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Patient-Reported Outcome Measures in a Clinical Trial of the Port Delivery System With Ranibizumab.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Spotlight on the DRCR Retina Network's Photobiomodulation for Diabetic Macular Edema Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Managing Center-Involved Diabetic Macular Edema With Good Visual Acuity.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy: A Post Hoc Analysis of a Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Interpreting Multiple Outcomes of Pupillary Light Reflex in Sport-Related Concussion in Adolescents.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Quantification of Fluid Resolution and Visual Acuity Gain in Patients With Diabetic Macular Edema Using Deep Learning: A Post Hoc Analysis of a Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Are P Values Enough?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab: A Post Hoc Analysis of the Protocol T Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Incorrect Data in Supplement.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Results of a Randomized Clinical Trial of Aflibercept vs Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Is It Time to Retire Your Laser?
- Published in:
- 2017
- By:
- Publication type:
- research
Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Interim Safety Data Comparing Ranibizumab With Panretinal Photocoagulation Among Participants With Proliferative Diabetic Retinopathy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Controversies in Using Off-Label Intravitreous Bevacizumab for Patients With Diabetic Macular Edema-Reply.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Controversies in Using Off-Label Intravitreous Bevacizumab for Patients With Diabetic Macular Edema.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluating Effects of Switching Anti-Vascular Endothelial Growth Factor Drugs for Age-Related Macular Degeneration and Diabetic Macular Edema.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Elimination of Topical Antibiotics for Intravitreous Injections and the Importance of Using Povidone-Iodine: Update From the Diabetic Retinopathy Clinical Research Network.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Panretinal Photocoagulation vs Anti-Vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy-Reply.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Novel Treatment for Proliferative Diabetic Retinopathy: Anti-Vascular Endothelial Growth Factor Therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Novel Treatment for Proliferative Diabetic Retinopathy.
- Published in:
- JAMA Ophthalmology, 2016, v. 134, n. 1, p. 13, doi. 10.1001/jamaophthalmol.2015.5079
- By:
- Publication type:
- Article
Considerations for randomizing 1 eye or 2 eyes.
- Published in:
- 2015
- By:
- Publication type:
- commentary
Comparative Effectiveness Trial for Diabetic Macular Edema.
- Published in:
- JAMA Ophthalmology, 2015, v. 133, n. 9, p. 983, doi. 10.1001/jamaophthalmol.2015.1880
- By:
- Publication type:
- Article
Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control.
- Published in:
- JAMA Ophthalmology, 2015, v. 133, n. 8, p. 888, doi. 10.1001/jamaophthalmol.2015.1312
- By:
- Publication type:
- Article
Repeated Intravitreous Ranibizumab Injections for Diabetic Macular Edema and the Risk of Sustained Elevation of Intraocular Pressure or the Need for Ocular Hypotensive Treatment.
- Published in:
- JAMA Ophthalmology, 2015, v. 133, n. 5, p. 589, doi. 10.1001/jamaophthalmol.2015.186
- By:
- Publication type:
- Article
Randomizing 1 eye or 2 eyes: a missed opportunity.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Randomizing 1 Eye or 2 Eyes.
- Published in:
- JAMA Ophthalmology, 2015, v. 133, n. 1, p. 9, doi. 10.1001/jamaophthalmol.2014.3600
- By:
- Publication type:
- Article
Evaluation of Results 1 Year Following Short-term Use of Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy.
- Published in:
- JAMA Ophthalmology, 2014, v. 132, n. 7, p. 889, doi. 10.1001/jamaophthalmol.2014.287
- By:
- Publication type:
- Article
Pilot Study of Individuals With Diabetic Macular Edema Undergoing Cataract Surgery.
- Published in:
- JAMA Ophthalmology, 2014, v. 132, n. 2, p. 224, doi. 10.1001/jamaophthalmol.2013.6209
- By:
- Publication type:
- Article